vs

Side-by-side financial comparison of Ingersoll Rand (IR) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

Ingersoll Rand is the larger business by last-quarter revenue ($2.1B vs $1.4B, roughly 1.5× PACS Group, Inc.). Ingersoll Rand runs the higher net margin — 12.7% vs 4.4%, a 8.3% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 10.1%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 11.9%).

Ingersoll Rand Inc. is an American multinational company that provides flow creation and industrial products. The company was formed in February 2020 through the spinoff of the industrial segment of Ingersoll-Rand plc and its merger with Gardner Denver. Its products are sold under more than 40 brands across all major global markets.

IR vs PACS — Head-to-Head

Bigger by revenue
IR
IR
1.5× larger
IR
$2.1B
$1.4B
PACS
Growing faster (revenue YoY)
PACS
PACS
+8.3% gap
PACS
18.4%
10.1%
IR
Higher net margin
IR
IR
8.3% more per $
IR
12.7%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
11.9%
IR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IR
IR
PACS
PACS
Revenue
$2.1B
$1.4B
Net Profit
$266.1M
$59.7M
Gross Margin
42.6%
Operating Margin
18.7%
7.0%
Net Margin
12.7%
4.4%
Revenue YoY
10.1%
18.4%
Net Profit YoY
15.8%
3022.5%
EPS (diluted)
$0.67
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IR
IR
PACS
PACS
Q4 25
$2.1B
$1.4B
Q3 25
$2.0B
$1.3B
Q2 25
$1.9B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$1.9B
$1.1B
Q3 24
$1.9B
$1.0B
Q2 24
$1.8B
$981.4M
Q1 24
$1.7B
$934.3M
Net Profit
IR
IR
PACS
PACS
Q4 25
$266.1M
$59.7M
Q3 25
$244.1M
$52.4M
Q2 25
$-115.3M
$51.0M
Q1 25
$186.5M
$28.5M
Q4 24
$229.8M
$1.9M
Q3 24
$221.6M
$15.6M
Q2 24
$185.0M
$-10.9M
Q1 24
$202.2M
$49.1M
Gross Margin
IR
IR
PACS
PACS
Q4 25
42.6%
Q3 25
43.7%
Q2 25
43.7%
Q1 25
44.6%
Q4 24
42.9%
Q3 24
43.8%
17.1%
Q2 24
43.9%
22.3%
Q1 24
44.7%
21.2%
Operating Margin
IR
IR
PACS
PACS
Q4 25
18.7%
7.0%
Q3 25
19.2%
6.4%
Q2 25
4.0%
6.2%
Q1 25
17.6%
3.8%
Q4 24
20.0%
1.7%
Q3 24
19.1%
2.2%
Q2 24
15.1%
0.1%
Q1 24
17.6%
8.6%
Net Margin
IR
IR
PACS
PACS
Q4 25
12.7%
4.4%
Q3 25
12.5%
3.9%
Q2 25
-6.1%
3.9%
Q1 25
10.9%
2.2%
Q4 24
12.1%
0.2%
Q3 24
11.9%
1.5%
Q2 24
10.2%
-1.1%
Q1 24
12.1%
5.3%
EPS (diluted)
IR
IR
PACS
PACS
Q4 25
$0.67
$0.42
Q3 25
$0.61
$0.32
Q2 25
$-0.29
$0.31
Q1 25
$0.46
$0.17
Q4 24
$0.57
$-0.03
Q3 24
$0.54
$0.10
Q2 24
$0.45
$-0.07
Q1 24
$0.50
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IR
IR
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$1.2B
$197.0M
Total DebtLower is stronger
$4.8B
$353.2M
Stockholders' EquityBook value
$10.1B
$946.8M
Total Assets
$18.3B
$5.6B
Debt / EquityLower = less leverage
0.47×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IR
IR
PACS
PACS
Q4 25
$1.2B
$197.0M
Q3 25
$1.2B
$355.7M
Q2 25
$1.3B
$294.2M
Q1 25
$1.6B
$287.5M
Q4 24
$1.5B
$157.7M
Q3 24
$1.4B
$49.5M
Q2 24
$1.1B
$73.4M
Q1 24
$1.5B
$81.2M
Total Debt
IR
IR
PACS
PACS
Q4 25
$4.8B
$353.2M
Q3 25
$4.8B
Q2 25
$4.8B
Q1 25
$4.8B
Q4 24
$4.8B
$411.9M
Q3 24
$4.8B
Q2 24
$4.8B
Q1 24
$2.7B
Stockholders' Equity
IR
IR
PACS
PACS
Q4 25
$10.1B
$946.8M
Q3 25
$10.1B
$871.3M
Q2 25
$10.1B
$806.8M
Q1 25
$10.5B
$750.2M
Q4 24
$10.2B
$709.6M
Q3 24
$10.3B
$660.0M
Q2 24
$10.0B
$572.1M
Q1 24
$9.9B
$128.0M
Total Assets
IR
IR
PACS
PACS
Q4 25
$18.3B
$5.6B
Q3 25
$18.2B
$5.6B
Q2 25
$18.1B
$5.5B
Q1 25
$18.4B
$5.5B
Q4 24
$18.0B
$5.2B
Q3 24
$18.2B
$4.5B
Q2 24
$17.8B
$3.9B
Q1 24
$15.5B
$3.9B
Debt / Equity
IR
IR
PACS
PACS
Q4 25
0.47×
0.37×
Q3 25
0.47×
Q2 25
0.47×
Q1 25
0.45×
Q4 24
0.47×
0.58×
Q3 24
0.47×
Q2 24
0.48×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IR
IR
PACS
PACS
Operating Cash FlowLast quarter
$499.0M
$-3.4M
Free Cash FlowOCF − Capex
$461.5M
FCF MarginFCF / Revenue
22.1%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
1.88×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IR
IR
PACS
PACS
Q4 25
$499.0M
$-3.4M
Q3 25
$354.6M
$204.8M
Q2 25
$245.7M
$52.6M
Q1 25
$256.4M
$150.2M
Q4 24
$526.2M
$64.6M
Q3 24
$404.0M
$209.2M
Q2 24
$304.9M
$34.8M
Q1 24
$161.6M
$58.8M
Free Cash Flow
IR
IR
PACS
PACS
Q4 25
$461.5M
Q3 25
$325.5M
Q2 25
$210.4M
Q1 25
$222.7M
Q4 24
$490.9M
Q3 24
$374.3M
Q2 24
$283.1M
Q1 24
$99.3M
FCF Margin
IR
IR
PACS
PACS
Q4 25
22.1%
Q3 25
16.6%
Q2 25
11.1%
Q1 25
13.0%
Q4 24
25.9%
Q3 24
20.1%
Q2 24
15.7%
Q1 24
5.9%
Capex Intensity
IR
IR
PACS
PACS
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.9%
Q1 25
2.0%
Q4 24
1.9%
Q3 24
1.6%
Q2 24
1.2%
Q1 24
3.7%
Cash Conversion
IR
IR
PACS
PACS
Q4 25
1.88×
-0.06×
Q3 25
1.45×
3.91×
Q2 25
1.03×
Q1 25
1.37×
5.28×
Q4 24
2.29×
33.78×
Q3 24
1.82×
13.39×
Q2 24
1.65×
Q1 24
0.80×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IR
IR

Transferred At Point In Time$1.5B71%
Transferred Over Time$193.0M9%
Precision And Science Technologies Segment$183.1M9%
Acquisitions In2024$175.6M8%
Acquisitions In2025$70.8M3%

PACS
PACS

Segment breakdown not available.

Related Comparisons